INTRODUCTION: Quantification of plasma viral load (PVL) is used to monitor disease progression in SIV-infected macaques. This study was aimed at optimizing of performance characteristics of the quantitative PCR (qPCR) PVL assay. METHODS: The PVL quantification procedure was optimized by inclusion of an exogenous control hepatitis C virus armored RNA (aRNA), a plasma concentration step, extended digestion with proteinase K, and a second RNA elution step. Efficiency of viral RNA (vRNA) extraction was compared using several commercial vRNA extraction kits. Various parameters of qPCR targeting the gag region of SIVmac239, SIVsmE660, and the LTR region of SIVagmSAB were also optimized. RESULTS: Modifications of the SIV PVL qPCR procedure increased vRNA recovery, reduced inhibition and improved analytical sensitivity. The PVL values determined by this SIV PVL qPCR correlated with quantification results of SIV RNA in the same samples using the 'industry standard' method of branched-DNA (bDNA) signal amplification. CONCLUSIONS: Quantification of SIV genomic RNA in plasma of rhesus macaques using this optimized SIV PVL qPCR is equivalent to the bDNA signal amplification method, less costly and more versatile. Use of heterologous aRNA as an internal control is useful for optimizing performance characteristics of PVL qPCRs.
INTRODUCTION: Quantification of plasma viral load (PVL) is used to monitor disease progression in SIV-infected macaques. This study was aimed at optimizing of performance characteristics of the quantitative PCR (qPCR) PVL assay. METHODS: The PVL quantification procedure was optimized by inclusion of an exogenous control hepatitis C virus armored RNA (aRNA), a plasma concentration step, extended digestion with proteinase K, and a second RNA elution step. Efficiency of viral RNA (vRNA) extraction was compared using several commercial vRNA extraction kits. Various parameters of qPCR targeting the gag region of SIVmac239, SIVsmE660, and the LTR region of SIVagmSAB were also optimized. RESULTS: Modifications of the SIV PVL qPCR procedure increased vRNA recovery, reduced inhibition and improved analytical sensitivity. The PVL values determined by this SIV PVL qPCR correlated with quantification results of SIV RNA in the same samples using the 'industry standard' method of branched-DNA (bDNA) signal amplification. CONCLUSIONS: Quantification of SIV genomic RNA in plasma of rhesus macaques using this optimized SIV PVL qPCR is equivalent to the bDNA signal amplification method, less costly and more versatile. Use of heterologous aRNA as an internal control is useful for optimizing performance characteristics of PVL qPCRs.
Authors: O M Diop; A Gueye; M Dias-Tavares; C Kornfeld; A Faye; P Ave; M Huerre; S Corbet; F Barre-Sinoussi; M C Müller-Trutwin Journal: J Virol Date: 2000-08 Impact factor: 5.103
Authors: Helen E White; John Hedges; Israel Bendit; Susan Branford; Dolors Colomer; Andreas Hochhaus; Timothy Hughes; Suzanne Kamel-Reid; Dong-Wook Kim; Vijay Modur; Martin C Müller; Katia B Pagnano; Fabrizio Pane; Jerry Radich; Nicholas C P Cross; Emmanuel Labourier Journal: Clin Chem Date: 2013-03-07 Impact factor: 8.327
Authors: Binhua Ling; Ronald S Veazey; Mike Hart; Andrew A Lackner; Marcelo Kuroda; Bapi Pahar; Preston A Marx Journal: AIDS Date: 2007-11-30 Impact factor: 4.177
Authors: Blake Schouest; Andrea M Weiler; Sanath Kumar Janaka; Tereance A Myers; Arpita Das; Sarah C Wilder; Jessica Furlott; Melody Baddoo; Erik K Flemington; Eva G Rakasz; David T Evans; Thomas C Friedrich; Nicholas J Maness Journal: J Virol Date: 2018-02-12 Impact factor: 5.103
Authors: Huanbin Xu; Widade Ziani; Jiasheng Shao; Lara A Doyle-Meyers; Kasi E Russell-Lodrigue; Marion S Ratterree; Ronald S Veazey; Xiaolei Wang Journal: J Immunol Date: 2018-08-13 Impact factor: 5.422
Authors: Ronald S Veazey; Udayan Chatterji; Michael Bobardt; Kasi E Russell-Lodrigue; Jian Li; Xiaolei Wang; Philippe A Gallay Journal: Antimicrob Agents Chemother Date: 2015-11-09 Impact factor: 5.191